Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Hallucinogen-based interventions may benefit substance use populations, but contemporary data informing the impact of hallucinogens on addictive behavior are scarce. Given that many individuals in the criminal justice system engage in problematic patterns of substance use, hallucinogen treatments also may benefit criminal justice populations. However, the relationship between hallucinogen use and criminal recidivism is unknown. In this longitudinal study, we examined the relationship between naturalistic hallucinogen use and recidivism among individuals under community corrections supervision with a history of substance involvement ( n=25,622). We found that hallucinogen use predicted a reduced likelihood of supervision failure (e.g. noncompliance with legal requirements including alcohol and other drug use) while controlling for an array of potential confounding factors (odds ratio (OR)=0.60 (0.46, 0.79)). Our results suggest that hallucinogens may promote alcohol and other drug abstinence and prosocial behavior in a population with high rates of recidivism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · cited 2×
“Although hallucinogen research has experienced a renaissance in the past few years (e.g., Carhart-Harris et al., 2012b; Grob et al., 2011; Schmidt et al., 2013; Sessa, 2007, 2012), results of clinical studies in substance use populations have not yet been reported outside of three successful…”
BackgroundHuman hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203
Self-citationNeural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172 · cited 3×
“…changes in pyramidal cell dendritic spine organization (Bogenschutz and Pommy, 2012), and changes in default mode network functional connectivity (Carhart-Harris et al., 2012a), although more research is needed to determine if these effects are associated with therapeutic effects in humans.”
BackgroundMacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111420188 · Cited by 895
Self-citationThe neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723 · cited 7×
“…are a class of psychoactive substances with low dependence potential that produce mystical-type experiences characterized by pseudo-hallucinations and feelings of bliss, unity, and transcendence of time and space (Griffiths et al., 2006; Johnson et al., 2008; Vollenweider and Kometer, 2010).”
BackgroundInfluentialTreating Drug Abuse and Addiction in the Criminal Justice System: Improving Public Health and Safety
Chandler, R. K., Fletcher, B. W., & Volkow, N. D. (2009) · JAMA · doi:10.1001/jama.2008.976 · Cited by 583 · cited 2×
“…involvement in the criminal justice system often results from drug-seeking behavior and impulsive conduct exacerbated by compulsive substance use (Chandler et al., 2009), and because individuals in the criminal justice system represent a recalcitrant population with numerous comorbid…”
BackgroundLysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Krebs, T. S., & Johansen, P.-Ø. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112439253 · Cited by 583 · cited 1×
“Indeed, a 2012 meta-analysis of six randomized clinical trials conducted between 1966–1970 found that a single dose of LSD administered in the context of treatment for alcoholism reduced alcohol misuse relative to comparison conditions (odds ratio (OR)=1.96; Krebs and Johansen, 2012).”
BackgroundInfluentialKetamine psychotherapy for heroin addiction: immediate effects and two-year follow-up
Krupitsky, E., Burakov, A., Romanova, T., Dunaevsky, I., Strassman, R., & Grinenko, A. (2002) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00275-1 · Cited by 246 · cited 2×
“Although hallucinogen research has experienced a renaissance in the past few years (e.g., Carhart-Harris et al., 2012b; Grob et al., 2011; Schmidt et al., 2013; Sessa, 2007, 2012), results of clinical studies in substance use populations have not yet been reported outside of three successful ketamine trials conducted…”
Result
Cited by
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.010 · Cited by 506
Self-citationHendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565653 · Cited by 381
Self-citationLappan, S. N., Brown, A. W., & Hendricks, P. S. (2020) · Addiction · doi:10.1111/add.14793 · Cited by 370
Self-citationAdolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods
Lisdahl, K. M., Sher, K. J., Conway, K. P., Gonzalez, R., Feldstein Ewing, S. W., Nixon, S. J., Tapert, S., Bartsch, H., Goldstein, R. Z., & Heitzeg, M. (2018) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2018.02.007 · Cited by 361
Metadata
- Authors
- Hendricks, P. S., Clark, C. B., Johnson, M. W., Fontaine, K. R., & Cropsey, K. L.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2014-01
- Volume
- 28
- Issue
- 1
- Pages
- 62-66
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W1996143523
- Cited by
- 88
- References
- 13
- FWCI
- 9.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. https://app.cochat.ai/papers/10.1177/0269881113513851
- The paper
- Hendricks, P. S., Clark, C. B., Johnson, M. W., Fontaine, K. R., & Cropsey, K. L. (2014). Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. Journal of Psychopharmacology. https://doi.org/10.1177/0269881113513851
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.